CelLBxHealth plc (AIM:CLBX)
0.9410
-0.0090 (-0.95%)
Mar 26, 2026, 3:22 PM GMT
CelLBxHealth Employees
CelLBxHealth had 119 employees as of December 31, 2024. The number of employees decreased by 31 or -20.67% compared to the previous year.
Employees
119
Change (1Y)
-31
Growth (1Y)
-20.67%
Revenue / Employee
22.05K GBP
Profits / Employee
-132.61K GBP
Market Cap
10.80M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 119 | -31 | -20.67% |
| Dec 31, 2023 | 150 | -20 | -11.76% |
| Dec 31, 2022 | 170 | 42 | 32.81% |
| Dec 31, 2021 | 128 | 26 | 25.49% |
| Dec 31, 2020 | 102 | 40 | 64.52% |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 96,100 |
| GSK plc | 66,841 |
| Haleon | 24,535 |
| Smith & Nephew | 16,988 |
| RUA Life Sciences | 59 |
| Renalytix | 46 |
| GENinCode | 42 |
| Oxford BioDynamics | 41 |
CelLBxHealth News
- 5 years ago - Angle PLC Announces Parsortix study uncovers targets in TNBC patients - Accesswire